|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing,locally advanced or metastatic gastric or gastroesophageal junction cancer:a single-arm phase II study显示文摘Background:Current treatment options for human epidermal growth factor receptor 2(HER2)-overexpressing gastric cancer at third-line have shown limited clinical benefit.Further,there is no specific treatment for HER2 immunohistochemistry(IHC)2+and fluorescence in-situ hybridization-negative patients.Here,we report the efficacy and safety of a novel anti-HER2 antibody RC48 for patients with HER2-overexpressing,advanced gastric or gastroesophageal junction cancer.Methods:Patients with HER2-overexpressing(IHC 2+or 3+),locally advanced or metastatic gastric or gastroesophageal junction cancer who were under at least second-line therapy were eligible and received RC482.5 mg/kg alone every 2 weeks.The primary endpoint was the objective response rate(ORR)assessed by an independent review committee.Secondary endpoints included progressionfree survival(PFS),overall survival(OS),duration of response,time to progression,disease control rate,and safety.Results:Of 179 patients screened,125 were eligible and received RC48 treatment.The ORR was 24.8%(95%confidence interval[CI]:17.5%-33.3%).The median PFS and OS were 4.1 months(95%CI:3.7-4.9 months)and 7.9 months(95%CI:6.7-9.9 months),respectively.The most frequently reported adverse events were decreased white blood cell count(53.6%),asthenia(53.6%),hair loss(53.6%),decreased neutrophil count(52.0%),anemia(49.6%),and increased aspartate aminotransferase level(43.2%).Serious adverse events(SAEs)occurred in 45(36.0%)patients,and RC48-related SAEs were mainly decreased neutrophil count(3.2%).Seven patients had adverse events that led to death were not RC48-related.Conclusions:RC48 showed promising activity with manageable safety,suggesting potential application in patients with HER2-overexpressing,advanced gastric or gastroesophageal junction cancer who have previously received at least two lines of chemotherapy. | Zhi Peng Tianshu Liu Jia Wei Airong Wang Yifu He Liuzhong Yang Xizhi Zhang Nanfeng Fan Suxia Luo Zhen Li Kangsheng Gu Jianwei Lu Jianming Xu Qingxia Fan Ruihua Xu Liangming Zhang Enxiao Li Yuping Sun Guohua Yu Chunmei Bai Yong Liu Jiangzheng Zeng Jieer Ying Xinjun Liang Nong Xu Chao Gao Yongqian Shu Dong Ma Guanghai Dai Shengmian Li Ting Deng Yuehong Cui Jianmin Fang Yi Ba Lin Shen | 2021 | Cancer Communications2021，41，11： | 29 |
| 2 | Probing primordial gravitational waves: Ali CMB Polarization Telescope显示文摘In this paper, we will give a general introduction to the Ali CMB Polarization Telescope(Ali CPT) project,which is a Sino–US joint project led by the Institute of High Energy Physics and involves many different institutes in China. It is the first ground-based Cosmic Microwave Background(CMB) polarization experiment in China and an integral part of China's Gravitational-wave Program. The main scientific goal of the Ali CPT project is to probe the primordial gravitational waves(PGWs) originating from the very early Universe. The AliCPT project includes two stages. The first stage, referred to as AliCPT-1, is to build a telescope in the Ali region of Tibet at an altitude of 5250 meters. Once completed, it will be the highest ground-based CMB observatory in the world and will open a new window for probing PGWs in the northern hemisphere. The AliCPT-1 telescope is designed to have about 7000 transition-edge sensor detectors at 95 GHz and 150 GHz. The second stage is to have a more sensitive telescope(Ali CPT-2) with more than 20 000 detectors. Our simulations show that AliCPT will improve the current constraint on the tensor-to-scalar ratio r by one order of magnitude with three years' observation. Besides the PGWs, Ali CPT will also enable a precise measurement of the CMB rotation angle and provide a precise test of the CPT symmetry. We show that three years' observation will improve the current limit by two orders of magnitude. | Hong Li Si-Yu Li Yang Liu Yong-Ping Li Yifu Cai Mingzhe Li Gong-Bo Zhao Cong-Zhan Liu Zheng-Wei Li He Xu Di Wu Yong-Jie Zhang Zu-Hui Fan Yong-Qiang Yao Chao-Lin Kuo Fang-Jun Lu Xinmin Zhang | 2019 | National Science Review2019，6，1： | 4 |
| 3 | Microvascular endothelial cells derived from spinal cord promote spinal cord injury repair显示文摘Neural regeneration after spinal cord injury (SCI) closely relates to the microvascular endothelial cell (MEC)- mediated neurovascular unit formation. However, the effects of central nerve system-derived MECs on neovascularization and neurogenesis, and potential signaling involved therein, are unclear. Here, we established a primary spinal cord-derived MECs (SCMECs) isolation with high cell yield and purity to describe the differences with brain-derived MECs (BMECs) and their therapeutic effects on SCI. Transcriptomics and proteomics revealed differentially expressed genes and proteins in SCMECs were involved in angiogenesis, immunity, metabolism, and cell adhesion molecular signaling was the only signaling pathway enriched of top 10 in differentially expressed genes and proteins KEGG analysis. SCMECs and BMECs could be induced angiogenesis by different stiffness stimulation of PEG hydrogels with elastic modulus 50-1650 Pa for SCMECs and 50-300 Pa for BMECs, respectively. Moreover, SCMECs and BMECs promoted spinal cord or brain-derived NSC (SNSC/BNSC) proliferation, migration, and differentiation at different levels. At certain dose, SCMECs in combination with the NeuroRegen scaffold, showed higher effectiveness in the promotion of vascular reconstruction. The potential underlying mechanism of this phenomenon may through VEGF/AKT/eNOS- signaling pathway, and consequently accelerated neuronal regeneration and functional recovery of SCI rats compared to BMECs. Our findings suggested a promising role of SCMECs in restoring vascularization and neural regeneration. | Zhifeng You Xu Gao Xinyi Kang Wen Yang Tiandi Xiong Yue Li Feng Wei Yan Zhuang Ting Zhang Yifu Sun He Shen Jianwu Dai | 2023 | Bioactive Materials2023，，11： | 2 |
| 4 | 新抗氧化因子iASPP通过与Nrf2竞争结合Keap1的方式促进肿瘤细胞生长和耐药显示文摘文章简介人类细胞不可避免地暴露于来自于外界(如UV)以及细胞内有氧代谢所产生的活性氧(reactive oxygen species,ROS)。少量ROS是调控细胞正常生理活动的重要信号分子,高水平ROS则会作用于细胞内包括DNA在内的生物大分子,致其损伤,破坏其功能,成为肿瘤发生的重要推动力。 | 葛文杰 赵坤明 Xingwen Wang Huayi Li Miao Yu Mengmeng He Xuting Xue Yifu Zhu 张诚 程易为 Shijian Jiang 胡颖 | 2018 | 科学新闻2018，0，4： | 0 |
| 5 | Effect of mulching with maize straw on water infiltration and soil loss at different initial soil moistures in a rainfall simulation显示文摘Mulching and soil water content(SWC) have a significant impact on soil erosion,and this study investigated the effect of straw mulching on water infiltration and soil loss under different initial SWC treatments in a rainfall simulation experiment conducted in northern China.Increasing initial SWC can decrease soil infiltration and increase soil loss.During an 80 mm rainfall event(80 mm·h–1for 60 min),8%,12% and 16% initial SWC treatments decreased cumulative infiltration by8.7%,42.5% and 58.1%,and increased total sediment yield by 44,146 and 315 g,respectively,compared to 4%initial SWC.However,in all the straw mulching treatments,there was no significant difference in stable infiltration rate between the different initial SWC treatments.For all initial SWC treatments,straw mulching of30% or more significantly enhanced water infiltration by over 31% and reduced soil loss by over 49%,compared to the unmulched treatment.Taking into consideration the performance of no-till planters,a maize straw mulching rate of 30% to 60%(1400–3100 kg·hm–2) is recommended for the conservation of water and soil in northern China. | Yifu ZHANG Hongwen LI Jin HE Qingjie WANG Ying CHEN Wanzhi CHEN Shaochun MA | 2016 | Frontiers of Agricultural Science and Engineering2016，3，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员